FDA Inspection 851840 — Shandong Anxin Pharmaceutical Co., Ltd.
The FDA completed an inspection of Shandong Anxin Pharmaceutical Co., Ltd. on Sep 27, 2013 in Jinan. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 27, 2013
- Fiscal Year
- 2013
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Jinan (China)